aTyr Pharma investors file class action securities lawsuit over alleged fraud.

Levi & Korsinsky, LLP is filing a class action lawsuit against aTyr Pharma, Inc. on behalf of investors who suffered losses due to alleged securities fraud between Nov. 7, 2024, and Sept. 12, 2025. The lawsuit seeks to recover losses for investors who were misled about the efficacy of Efzofitimod, a drug developed by the company. Investors who were adversely affected can contact Levi & Korsinsky for more information and to be contacted by a team member.